Dr. Stephanie Goyena Gilibert, MD

Dr. Gilibert practices at U.S. Renal Care Hilo Dialysis in Honolulu, Hawaii.

Dr. Gilibert's NPI, 1972540789, was assigned on June 1, 2006. Dr. Gilibert graduated from Drexel University College Of Medicine in 2000. Dr. Gilibert holds Hawaii license MD-22582.

Dr. Gilibert's primary practice is U.S. Renal Care Hilo Dialysis, at 1520 Liliha St, Honolulu, HI 96817 in Honolulu County. The practice phone is (808) 909-3996.

Dr. Gilibert's primary practice is U.S. Renal Care Hilo Dialysis in Honolulu, Hawaii. Dr. Gilibert is also affiliated with Hilo Benioff Medical Center. The medical group on file is Hawaii Kidney Specialists. Dmand AI also links Dr. Gilibert to 3 more dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilibert practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gilibert's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gilibert is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Gilibert's licenses on file in 4 states: Hawaii, Delaware, Maryland and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and parathyroid gland disorder among the conditions Dr. Gilibert treats.

CMS data shows 716 Medicare services from Dr. Gilibert across 11 procedure codes in 2024, for 216 Medicare patients. Medicare paid $76,283 for them.

CMS counts 216 Medicare patients who saw Dr. Gilibert in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gilibert's median patient age at 72, with 45% women.

In 2024, Dr. Gilibert wrote 2,017 Medicare Part D claims for 302 patients. 81% of them were for generic drugs. CMS names the drug for 1,763 of them, across 35 drugs with 11 or more claims each, at $592,758 in total drug cost. In 2023, CMS named 770 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gilibert for performance year 2024, reported as part of a group. Dr. Gilibert accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Gilibert. Dr. Gilibert's most frequent co-authors are Brian M. Aboff, MD and Neil J. Farber, MD.

CMS Open Payments shows 112 general payments to Dr. Gilibert from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. AstraZeneca Pharmaceuticals LP paid the most, $545.

Dr. Gilibert graduated from Drexel University College Of Medicine in 2000.

Dr. Gilibert is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.